Chaoyi Yuan

机构：Tongji Hospital, Huazhong University of Science and Technology

发表论文 23 篇 · 总被引 542 次 · h-index 9

代表论文

• Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma (2020 · Experimental Hematology and Oncology · 被引 198)
• The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway (2020 · Theranostics · 被引 96)
• Cancer stem cells and niches: challenges in immunotherapy resistance (2025 · Molecular Cancer · 被引 86)
• CRISPR/Cas9‐mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV‐positive hepatocellular carcinoma cells (2018 · Journal of Cellular Biochemistry · 被引 55)
• Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway (2022 · Cellular Oncology · 被引 37)
• DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages (2024 · Clinical and Translational Medicine · 被引 14)